気管内チューブ：市場洞察・競合情勢・市場予測 (～2032年)

気管内チューブの市場規模は、2024年の15億8,267万米ドルから、予測期間中はCAGR 4.09％で推移し、2032年には21億7,359万米ドルの規模に成長すると予測されています。

慢性呼吸器疾患や腫瘍性疾患の有病率の上昇、外科手術や外傷症例の増加が、気管内チューブの需要を促進しています。加えて、抗菌コートチューブや主要参入企業による改良デザインなどのイノベーションが、その採用を後押ししています。これらの要因が相まって、気管内チューブの世界市場は拡大しており、予測期間中の市場成長をさらに促進しています。

市場力学：

世界の気管内チューブ市場は、慢性呼吸器疾患の有病率の増加、癌患者の増加、技術の進歩に牽引され、大きな成長を遂げようとしています。

オーストラリア保健福祉研究所 (Australian Institute of Health and Welfare) によると (2022年)、オーストラリアの人口の34％にあたる約850万人が慢性呼吸器疾患を患っていると推定されています。世界規模では、Global Burden of Disease (2023年) によると、20人に1人が慢性呼吸器疾患を患っていると報告されています。これらの疾患はしばしば重度の呼吸困難を引き起こし、気道管理を含む頻繁な医療介入が必要となります。緊急なシナリオでは、適切な酸素供給を維持するために機械的換気が不可欠であり、気管内チューブはそのような処置における主要な手段です。汚染、喫煙、高齢化といった要因が呼吸器系疾患の世界の発生率を押し上げ続けており、気管内チューブ市場の需要に拍車をかけています。

これと並行して、世界の癌罹患率の上昇が市場成長をさらに加速させています。GLOBOCAN (2022) によると、世界で新たに発生した癌患者は推定2,000万人で、2045年には3,260万人に増加すると予測されています。多くの癌患者、特に呼吸器関連の手術を受ける患者は、挿管による気道管理を必要とします。例えば、肺癌患者は、生検、腫瘍切除、術後ケアなどの処置中に呼吸困難に直面することが多く、そのすべてに気管内チューブが必要となります。さらに、化学療法や放射線療法などの癌治療は、気道閉塞や呼吸不全などの合併症を引き起こす可能性があり、機械的換気装置の需要をさらに高めています。

技術的進歩も市場成長の推進に重要な役割を果たしています。2021年11月、GE Healthcareは、気管内チューブ留置を支援するために設計された初のX線AIソリューションのFDA認可を取得しました。GE HealthcareのCritical Care Suite 2.0の一部であるこのAIツールは、モバイルX線装置に統合された業界初のAIアルゴリズムのコレクションであり、自動測定、症例の優先順位付け、品質管理を提供します。このような技術革新は、処置の正確性を高め、配置ミスを減らし、患者の転帰を改善し、気管内チューブの採用率をさらに押し上げます。

こうした成長促進要因にもかかわらず、市場は課題にも直面しています。人工呼吸器関連肺炎 (VAP) のリスクとともに、歯、声帯、気管を損傷する可能性を含む挿入時の合併症が市場拡大の妨げになる可能性があります。こうしたリスクは、有害な結果を軽減するための継続的なトレーニング、機器設計の改善、安全プロトコルの遵守の必要性を浮き彫りにしています。

当レポートでは、世界の気管内チューブの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 気管内チューブ市場レポート：イントロダクション

第2章 気管内チューブ市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 気管内チューブ市場：主要要因分析

• 市場促進要因
  • 慢性呼吸器疾患および癌の罹患率の増加
  • 外科手術の増加
  • 外傷や事故の増加
• 市場抑制要因と課題
  • 挿入時の合併症のリスク
  • 安全性に関する製品リコールの増加
• 市場機会
  • より安全で技術的に進歩した気管内チューブの開発

第6章 気管内チューブ市場：ポーターのファイブフォース分析

第7章 気管内チューブ市場：市場の評価

• 製品タイプ別
  • 標準
  • 強化
  • コーティング
  • その他
• カフタイプ別
  • カフあり
  • カフなし/カフレス
• 挿管経路別
  • 経口
  • 鼻腔
  • その他
• 年齢別
  • 成人
  • 小児
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 気管内チューブ市場：企業と製品のプロファイル

• Medtronic PLC
• Smiths Medical
• Teleflex Incorporated
• VYAIRE MEDICAL, INC.
• Avanos Medical, Inc.
• ConvaTec, Inc.
• BACTIGUARD AB
• Vygon
• N8 Medical, LLC
• Novo Klinik-Service GmbH
• Intersurgical Ltd.
• Salter Labs (SunMed)
• Angiplast Pvt Ltd.
• Guangzhou Orcl Medical Co.,Ltd.
• ROYAX, S.R.O
• Sumi
• HUM Gesellschaft fur Homecare und Medizintechnik mbH
• MEDADV Medical
• Van Oostveen Medical B.V.
• DEAS S.R.L

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Endotracheal Tubes Market in Global (2022-2032)
• Table 3: Endotracheal Tubes Market in Global by Product Type (2022-2032)
• Table 4: Endotracheal Tubes Market in Global by Cuff Type (2022-2032)
• Table 5: Endotracheal Tubes Market in Global by Intubation Tube (2022-2032)
• Table 6: Endotracheal Tubes Market in Global by Age Group (2022-2032)
• Table 7: Endotracheal Tubes Market in Global by End-User (2022-2032)
• Table 8: Endotracheal Tubes Market in Global by Geography (2022-2032)
• Table 9: Endotracheal Tubes Market in North America (2022-2032)
• Table 10: Endotracheal Tubes Market in the United States (2022-2032)
• Table 11: Endotracheal Tubes Market in Canada (2022-2032)
• Table 12: Endotracheal Tubes Market in Mexico (2022-2032)
• Table 13: Endotracheal Tubes Market in Europe (2022-2032)
• Table 14: Endotracheal Tubes Market in France (2022-2032)
• Table 15: Endotracheal Tubes Market in Germany (2022-2032)
• Table 16: Endotracheal Tubes Market in United Kingdom (2022-2032)
• Table 17: Endotracheal Tubes Market in Italy (2022-2032)
• Table 18: Endotracheal Tubes Market in Spain (2022-2032)
• Table 19: Endotracheal Tubes Market in the Rest of Europe (2022-2032)
• Table 20: Endotracheal Tubes Market in Asia-Pacific (2022-2032)
• Table 21: Endotracheal Tubes Market in China (2022-2032)
• Table 22: Endotracheal Tubes Market in Japan (2022-2032)
• Table 23: Endotracheal Tubes Market in India (2022-2032)
• Table 24: Endotracheal Tubes Market in Australia (2022-2032)
• Table 25: Endotracheal Tubes Market in South Korea (2022-2032)
• Table 26: Endotracheal Tubes Market in Rest of Asia-Pacific (2022-2032)
• Table 27: Endotracheal Tubes Market in the Rest of the World (2022-2032)
• Table 28: Endotracheal Tubes Market in the Middle East (2022-2032)
• Table 29: Endotracheal Tubes Market in Africa (2022-2032)
• Table 30: Endotracheal Tubes Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Endotracheal Tubes Market in Global (2022-2032)
• Figure 3: Endotracheal Tubes Market in Global by Product Type (2022-2032)
• Figure 4: Endotracheal Tubes Market in Global by Cuff Type (2022-2032)
• Figure 5: Endotracheal Tubes Market in Global by Intubation Tube (2022-2032)
• Figure 6: Endotracheal Tubes Market in Global by Age Group (2022-2032)
• Figure 7: Endotracheal Tubes Market in Global by End-User (2022-2032)
• Figure 8: Endotracheal Tubes Market in Global by Geography (2022-2032)
• Figure 9: Endotracheal Tubes Market in North America (2022-2032)
• Figure 10: Endotracheal Tubes Market in the United States (2022-2032)
• Figure 11: Endotracheal Tubes Market in Canada (2022-2032)
• Figure 12: Endotracheal Tubes Market in Mexico (2022-2032)
• Figure 13: Endotracheal Tubes Market in Europe (2022-2032)
• Figure 14: Endotracheal Tubes Market in France (2022-2032)
• Figure 15: Endotracheal Tubes Market in Germany (2022-2032)
• Figure 16: Endotracheal Tubes Market in United Kingdom (2022-2032)
• Figure 17: Endotracheal Tubes Market in Italy (2022-2032)
• Figure 18: Endotracheal Tubes Market in Spain (2022-2032)
• Figure 19: Endotracheal Tubes Market in the Rest of Europe (2022-2032)
• Figure 20: Endotracheal Tubes Market in Asia-Pacific (2022-2032)
• Figure 21: Endotracheal Tubes Market in China (2022-2032)
• Figure 22: Endotracheal Tubes Market in Japan (2022-2032)
• Figure 23: Endotracheal Tubes Market in India (2022-2032)
• Figure 24: Endotracheal Tubes Market in Australia (2022-2032)
• Figure 25: Endotracheal Tubes Market in South Korea (2022-2032)
• Figure 26: Endotracheal Tubes Market in Rest of Asia-Pacific (2022-2032)
• Figure 27: Endotracheal Tubes Market in the Rest of the World (2022-2032)
• Figure 28: Endotracheal Tubes Market in the Middle East (2022-2032)
• Figure 29: Endotracheal Tubes Market in Africa (2022-2032)
• Figure 30: Endotracheal Tubes Market in South America (2022-2032)
• Figure 31: Market Drivers
• Figure 32: Market Barriers
• Figure 33: Market Opportunities
• Figure 34: PORTER'S Five Force Analysis

Endotracheal Tube Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of chronic respiratory and oncological disorders, growing surgical procedures, rising number of trauma and accident cases, and increase in product development activities by key market players across the globe.

The endotracheal tubes market was valued at USD 1,582.67 million in 2024, growing at a CAGR of 4.09% during the forecast period from 2025 to 2032 to reach USD 2,173.59 million by 2032. The rising prevalence of chronic respiratory and oncological disorders, along with an increase in surgical procedures and trauma cases, is driving demand for endotracheal tubes. Additionally, innovations like antimicrobial-coated tubes and improved designs by key market players are boosting their adoption. Together, these factors are expanding the global market for endotracheal tubes further propelling the market growth during the forecast period from 2025 to 2032.

Endotracheal Tubes Market Dynamics:

The global endotracheal tubes market is poised for significant growth, driven by the increasing prevalence of chronic respiratory conditions, rising cancer cases, and technological advancements.

According to the Australian Institute of Health and Welfare (2022), approximately 8.5 million people, or 34% of Australia's population were estimated to have chronic respiratory conditions. On a global scale, the Global Burden of Disease (2023) reported that 1 in 20 individuals suffers from chronic respiratory diseases. These conditions often lead to severe breathing difficulties, necessitating frequent medical interventions that involve airway management. In critical scenarios, mechanical ventilation is essential to maintain proper oxygenation, with endotracheal tubes being a primary tool in such procedures. Factors like pollution, smoking, and aging populations continue to drive the global incidence of respiratory diseases, thereby fueling market demand for endotracheal tubes.

In parallel, the rising global burden of cancer further escalates market growth. As per GLOBOCAN (2022), there were an estimated 20 million new cancer cases globally, with projections indicating an increase to 32.6 million by 2045 . Many cancer patients particularly those undergoing respiratory-related surgeries require airway management through intubation. For instance, lung cancer patients often face breathing difficulties during procedures such as biopsies, tumor resections, and post-operative care, all of which necessitate endotracheal tubes. Additionally, cancer treatments like chemotherapy and radiation may cause complications such as airway obstruction or respiratory failure, further increasing the demand for mechanical ventilation devices.

Technological advancements are also playing a crucial role in propelling market growth. In November 2021, GE Healthcare received FDA clearance for the first X-ray artificial intelligence (AI) solution designed to assist in endotracheal tube placement. This AI tool, part of GE Healthcare's Critical Care Suite 2.0, is an industry-first collection of AI algorithms integrated into a mobile X-ray device, offering automated measurements, case prioritization, and quality control. Such innovations enhance procedural accuracy, reduce placement errors, and improve patient outcomes, further boosting adoption rates of endotracheal tubes.

Despite these growth drivers, the market faces challenges. Complications during insertion, including potential damage to teeth, vocal cords, or the trachea, along with the risk of ventilator-associated pneumonia (VAP), may hinder market expansion. These risks highlight the need for ongoing training, improved device designs, and adherence to safety protocols to mitigate adverse outcomes.

In conclusion, the interplay of rising chronic respiratory diseases, increasing cancer prevalence, and technological innovations is expected to drive the global endotracheal tube market. However, addressing procedural risks and infection control remains vital to sustain long-term growth.

Endotracheal Tubes Market Segment Analysis:

Endotracheal Tubes Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the cuff type segment of the overall endotracheal tubes market, the cuffed endotracheal tubes are expected to hold the largest share in the year 2024. Cuffed endotracheal tubes are increasingly driving the growth of the endotracheal tube market due to their advanced design and substantial benefits in airway management. The primary advantage of cuffed endotracheal tubes lies in the cuff a balloon-like component that inflates once the tube is in place, creating a seal around the trachea. This seal is critical for ensuring that the airway remains secure, preventing air leaks, and reducing the risk of aspiration, which occurs when stomach contents enter the lungs. Additionally, cuffed endotracheal tubes allow for more precise control of ventilation pressures, which is crucial for patients requiring mechanical ventilation. The ability to adjust cuff pressure helps optimize ventilation and minimizes the risk of ventilator-associated pneumonia (VAP) by reducing the potential for contamination and infection. This is especially important in intensive care units (ICUs) and emergency settings where patients are at high risk for such infections.

The market for cuffed endotracheal tubes is further bolstered by ongoing innovations in cuff technology and materials. Modern cuff designs use advanced materials that are less prone to air leaks and are more comfortable for patients. These improvements contribute to better patient outcomes and higher safety standards, making cuffed tubes a preferred choice in many clinical scenarios thereby boosting the overall market of cuffed endotracheal tubes.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global endotracheal tubes market during the forecast period.

North America is expected to dominate the overall Endotracheal Tubes market:

Among all the regions, North America is expected to hold the largest share of the global endotracheal tubes market in 2024. The growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region. Additionally, recent product developmental activities such as product approval and launches are expected to aid in the growth of the North American endotracheal tubes market during the forecast period from 2025 to 2032.

As per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, emphysema, and chronic bronchitis cause severe breathing difficulties and frequent exacerbations, often requiring intubation and mechanical ventilation in advanced stages. Endotracheal tubes are essential for securing the airway and providing precise ventilation support for the patients thereby escalating the overall market across the region. Furthermore, as per the recent data and stats provided by the Centre for Disease Control and Prevention (2023), in 2022, the admission rate of mothers to an intensive care unit (ICU) during delivery hospitalization was 1.8 per 1,000 live births. The admission rate of mothers to an intensive care unit (ICU) can significantly boost the market for endotracheal tubes due to the critical need for airway management in severe obstetric complications. Conditions such as severe preeclampsia, postpartum hemorrhage, or complications during labor and delivery may necessitate emergency intubation and mechanical ventilation to ensure maternal safety and optimal respiratory support thereby boosting the overall market of endotracheal tubes.

According to the recent data and stats provided by the Centre for Disease Control and Prevention (2024), there were 24.8 million physician office visits and 25.5 million emergency department visits for unintentional road traffic injuries. Road traffic accidents often cause severe injuries that impair breathing, requiring immediate airway management. Endotracheal tubes are essential for securing the airway, ensuring proper ventilation, and preventing complications in emergency settings. The high frequency of such accidents drives demand for these tubes to manage critical airway needs efficiently.

Therefore, the interplay of the above-mentioned factors in the region is expected to boost the North America endotracheal tubes market during the forecast period.

Endotracheal Tubes Market Key Players:

Some of the key market players operating in the endotracheal Tubes market include Medtronic PLC, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc., ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co., Ltd., ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.

Recent Developmental Activities in the Endotracheal Tubes Market:

• In August 2021, in a proof-of-concept study, researchers at Children's Hospital of Philadelphia (CHOP) developed a coating that could be applied to endotracheal tubes to release antimicrobial peptides targeting specific infectious bacteria. This innovation had the potential to reduce upper-airway bacterial inflammation during intubation, a condition that can lead to chronic inflammation and subglottic stenosis, where the airway narrows due to an accumulation of scar tissue.

Key Takeaways from the Endotracheal Tubes Market Report Study:

• Market size analysis for current endotracheal tubes size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the endotracheal tubes market.
• Various opportunities available for the other competitors in the endotracheal tubes market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current endotracheal tubes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for endotracheal tube market growth in the coming future?

Target Audience Who Can be Benefited from this Endotracheal Tubes Market Report Study:

• Endotracheal tube product providers
• Research organizations and consulting companies
• Endotracheal tubes -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in endotracheal tubes
• Various end-users who want to know more about the endotracheal tubes market and the latest technological developments in the endotracheal tubes market.

Frequently Asked Questions for the Endotracheal Tubes Market:

1. What are endotracheal tubes?

• Endotracheal tubes are medical devices inserted into the trachea to maintain an open airway and provide ventilation to patients, commonly used during surgery or in emergencies.

2. What is the market for endotracheal tubes?

• The endotracheal tubes market was valued at USD 1,582.67 million in 2024, growing at a CAGR of 4.09% during the forecast period from 2025 to 2032 to reach USD 2,173.59 million by 2032.

3. What are the drivers for the endotracheal tube market?

• The rising prevalence of chronic respiratory disorders and cancer, along with an increase in surgical procedures and trauma cases, is driving demand for endotracheal tubes. Additionally, innovations like antimicrobial-coated tubes and improved designs by key market players are boosting their adoption. Together, these factors are expanding the global market for endotracheal tubes further propelling the market growth during the forecast period from 2025 to 2032.

4. Who are the key players operating in the endotracheal tube market?

• Some of the key market players operating in the endotracheal tubes market include Medtronic PLC, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc., ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co., Ltd., ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.

5. Which region has the highest share in the endotracheal tubes market?

• Among all the regions, North America is expected to hold the largest share of the global endotracheal tubes market in 2024. The growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region. Additionally, recent product developmental activities and rising government initiatives are expected to aid in the growth of the North American endotracheal tubes market during the forecast period from 2025 to 2032.

Table of Contents

1. Endotracheal Tubes Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Endotracheal Tubes Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Endotracheal Tubes Market Key Factors Analysis

• 5.1. Endotracheal Tubes Market Drivers
  • 5.1.1. Increasing prevalence of chronic respiratory disorders and cancer cases
  • 5.1.2. Growing surgical procedures
  • 5.1.3. Rising number of trauma and accident cases
• 5.2. Endotracheal Tubes Market Restraints and Challenges
  • 5.2.1. Risk of complication during insertion of endotracheal tubes
  • 5.2.2. Increased number of product recalls due to safety
• 5.3. Endotracheal Tubes Market Opportunities
  • 5.3.1. Development of safer and technologically advanced endotracheal tubes

6. Endotracheal Tubes Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Endotracheal Tubes Market Assessment

• 7.1. By Product Type
  • 7.1.1. Standard
  • 7.1.2. Reinforced
  • 7.1.3. Coated
  • 7.1.4. Other
• 7.2. By Cuff Type
  • 7.2.1. Cuffed
  • 7.2.2. Uncuffed/Cuffless
• 7.3. By Intubation Route
  • 7.3.1. Oral
  • 7.3.2. Nasal
  • 7.3.3. Others
• 7.4. By Age Group
  • 7.4.1. Adult
  • 7.4.2. Pediatric
• 7.5. By End-User
  • 7.5.1. Hospitals
  • 7.5.2. Ambulatory Surgical Centers
  • 7.5.3. Others
• 7.6. By Geography
  • 7.6.1. North America
    • 7.6.1.1. United States Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.1.2. Canada Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.1.3. Mexico Endotracheal Tubes Market Size in USD Million (2022-2032)
  • 7.6.2. Europe
    • 7.6.2.1. France Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.2.2. Germany Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.2.3. United Kingdom Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.2.4. Italy Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.2.5. Spain Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.2.6. Rest of Europe Endotracheal Tubes Market Size in USD Million (2022-2032)
  • 7.6.3. Asia-Pacific
    • 7.6.3.1. China Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.3.2. Japan Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.3.3. India Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.3.4. Australia Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.3.5. South Korea Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.3.6. Rest of Asia-Pacific Endotracheal Tubes Market Size in USD Million (2022-2032)
  • 7.6.4. Rest of the World (RoW)
    • 7.6.4.1. Middle East Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.4.2. Africa Endotracheal Tubes Market Size in USD Million (2022-2032)
    • 7.6.4.3. South America Endotracheal Tubes Market Size in USD Million (2022-2032)

8. Endotracheal Tubes Market Company and Product Profiles

• 8.1. Medtronic PLC
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Smiths Medical
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Teleflex Incorporated
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. VYAIRE MEDICAL, INC.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Avanos Medical, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. ConvaTec, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. BACTIGUARD AB
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Vygon
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. N8 Medical, LLC
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Novo Klinik-Service GmbH
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Intersurgical Ltd.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Salter Labs (SunMed)
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Angiplast Pvt Ltd.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Guangzhou Orcl Medical Co.,Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. ROYAX, S.R.O
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Sumi
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. HUM Gesellschaft fur Homecare und Medizintechnik mbH
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. MEDADV Medical
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Van Oostveen Medical B.V.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. DEAS S.R.L
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us